This article highlights the growing scientific and clinical focus on smell disorders like anosmia and parosmia, which were previously underdiagnosed and minimized. The COVID-19 pandemic significantly accelerated research into these conditions, revealing that a large portion of the population suffers from smell impairments, often with lasting effects.
Background
Smell disorders affect a significant portion of the global population but have historically received less medical attention compared to other sensory deficits. The high prevalence of smell loss as a symptom of COVID-19 has driven recent advancements in understanding olfactory biology and treatment.
- Source
- Ars Technica
- Published
- Jul 4, 2026 at 07:04 PM
- Score
- 6.0 / 10